WHAT YOU NEED TO KNOW This month, The Hill published a timely op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse.  Lane penned this piece amidst the COVID-19 pandemic to highlight the need to make sure our drug laws are working to encourage innovation and public-private partnerships for the development of needed drugs while […]

Continue Reading

WHAT YOU NEED TO KNOW According to recent reporting from Reuters, lawmakers are watching closely how Gilead will price their drug remdesivir. Remdesivir, which was developed in part through taxpayer funding, has been touted as a potential treatment for COVID-19. “But it has sued Gilead over patents on two of its widely-used HIV drugs that received federal […]

Continue Reading